Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Epigenetic regulation linked with pathogenesis of Alzheimer's disease

New evidence presented at the 26th ECNP Congress linking epigenetic regulation with Alzheimer's disease may one day lead to new early diagnostic tests and even novel treatment options for the most common form of dementia.

7 Oct 2013

Researchers identify protein that triggers inflammation in patients with hemorrhage, sepsis

Investigators at The Feinstein Institute for Medical Research have discovered a protein in the human body that can trigger and mediate inflammation in patients suffering from hemorrhage and sepsis. The findings were published in the online version of Nature Medicine on October 6, 2013.

7 Oct 2013

Newly opened Manchester-based DNA bank may support discoveries on motor neuron disease

A specialist DNA Bank, based at The University of Manchester, is now open to the worldwide research community, supporting more crucial discoveries about motor neurone disease (MND), a devastating terminal illness.

5 Oct 2013

Researchers develop app to encourage and support cognitive creativity by dementia caregivers

Dementia is an ageing-related condition affecting mental acuity and memory. Incidence doubles in a population for every five years over the age of 65 years, so that almost one fifth of those living to 85 can expect to have the condition and a third of those over the age of 95 will likely be affected.

5 Oct 2013

Study suggests that surgery may be effective treatment for epilepsy in older patients

A recently published study by researchers from Spectrum Health and Henry Ford Hospital suggests that surgery may be an effective treatment for epilepsy in older patients, a finding that runs counter to conventional treatment methods.

3 Oct 2013

Depressed people may have triple times risk of developing Parkinson's

People who are depressed may have triple the risk of developing Parkinson's disease, according to a study published in the October 2, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology.

3 Oct 2013

Adamas Pharmaceuticals reports positive results from ADS-5102 Phase 2/3 EASED clinical trial

Adamas Pharmaceuticals, Inc. presented positive results today from the Phase 2/3 EASED clinical trial of ADS-5102 at the World Parkinson's Congress. ADS-5102 is Adamas' proprietary long-acting capsule formulation of amantadine HCl in development for the treatment of levodopa-induced dyskinesia in Parkinson's disease patients.

2 Oct 2013

NIMH Awards Optivia $1.8M CNS Drug Development

...

2 Oct 2013

Statin medications pose no threat to short-term memory and may protect against dementia

A review of dozens of studies on the use of statin medications to prevent heart attacks shows that the commonly prescribed drugs pose no threat to short-term memory, and that they may even protect against dementia when taken for more than one year.

2 Oct 2013

Merck & Co. Axes 8,500 In R&D Restructuring

...

1 Oct 2013

Merck & Co. Axes 8,500 In R&D Restructuring

...

1 Oct 2013

GSA awarded $5M grant to launch Hartford Change AGEnts Initiative to improve health of older adults

The Gerontological Society of America has been awarded a $5 million grant from the John A. Hartford Foundation to launch and develop the Hartford Change AGEnts Initiative, a multi-year project designed to create change in the practice environment that will improve the health of older adults, their families, and communities.

1 Oct 2013

UCSB study demonstrates new tool to resolve structure of membrane proteins

Membrane proteins are responsible for transporting chemicals and messages between a cell and its environment. But determining their structure has proved challenging for scientists. A study by UC Santa Barbara's Han Research Group demonstrates a new tool to resolve the structure of membrane-embedded and membrane-associating proteins using the water dynamics gradient they found across and above the lipid bilayer as a unique ruler.

1 Oct 2013

Shortage of zinc may contribute to diseases like Alzheimer's and Parkinson's

Scientists at the University of Wisconsin-Madison have made a discovery that, if replicated in humans, suggests a shortage of zinc may contribute to diseases like Alzheimer's and Parkinson's, which have been linked to defective proteins clumping together in the brain.

1 Oct 2013

Roadmap of protein interactions may lead to new therapeutic approaches for type 2 diabetes

A team led by scientists at The Scripps Research Institute (TSRI) has created the first comprehensive roadmap of the protein interactions that enable cells in the pancreas to produce, store and secrete the hormone insulin.

1 Oct 2013

Long sleep duration accelerates cognitive decline

People with long sleep durations of more than 9 hours daily have more rapid cognitive decline than those who sleep 6 to 8 hours, researchers report.

30 Sep 2013

Research roundup: Managed care for dementia patients; bundled payments after the hospital; disparities among Medicare beneficiaries

Dementia is a leading cause of death in the United States; however, patients dying with this disease may not receive optimal end-of-life care. ... many of these [nursing home] residents commonly experience burdensome and costly interventions, such as hospital transfers, tube-feeding, and intravenous antibiotics. ... Nursing home reimbursement policies are among the factors that incentivize more aggressive care. ... This study linked unique prospective clinical data with Medicare claims to describe and compare patterns of care between nursing home residents with advanced dementia enrolled in a Medicare managed-care insurance plan and those with fee-for-service Medicare.

30 Sep 2013

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Epigenetic regulation linked with pathogenesis of Alzheimer's disease

Researchers identify protein that triggers inflammation in patients with hemorrhage, sepsis

Newly opened Manchester-based DNA bank may support discoveries on motor neuron disease

Researchers develop app to encourage and support cognitive creativity by dementia caregivers

Study suggests that surgery may be effective treatment for epilepsy in older patients

Depressed people may have triple times risk of developing Parkinson's

Adamas Pharmaceuticals reports positive results from ADS-5102 Phase 2/3 EASED clinical trial

NIMH Awards Optivia $1.8M CNS Drug Development

Statin medications pose no threat to short-term memory and may protect against dementia

Merck & Co. Axes 8,500 In R&D Restructuring

Merck & Co. Axes 8,500 In R&D Restructuring

GSA awarded $5M grant to launch Hartford Change AGEnts Initiative to improve health of older adults

UCSB study demonstrates new tool to resolve structure of membrane proteins

Shortage of zinc may contribute to diseases like Alzheimer's and Parkinson's

Roadmap of protein interactions may lead to new therapeutic approaches for type 2 diabetes

Long sleep duration accelerates cognitive decline

Research roundup: Managed care for dementia patients; bundled payments after the hospital; disparities among Medicare beneficiaries

Medical imaging website compiles list of hottest clinical procedures in imaging for AD

Childhood abuse, lack of parental affection may increase health risk in adulthood

Researchers to use state-of-the-art brain imaging to study mucopolysaccharidosis

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in